Home  >  Products  >  TAPT1 (transmembrane anterior posterior transformation 1 ) Blocking Peptide (the C terminal of TAPT1)(100ug)
TAPT1 (transmembrane anterior posterior transformation 1 ) Blocking Peptide (the C terminal of TAPT1)(100ug)

TAPT1 (transmembrane anterior posterior transformation 1 ) Blocking Peptide (the C terminal of TAPT1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TAPT1 Antibody (ARP67839_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP67839
Size: 100ug
Weight: 62kDa
Gene: 202018
Format: Lyophilized powder
Target: This gene encodes a highly conserved, putative transmembrane protein. A mutation in the mouse ortholog of this gene results in homeotic, posterior-to-anterior transformations of the axial skeleton which are similar to the phenotype of mouse homeobox C8 gene mutants. This gene is proposed to function downstream of homeobox C8 to transduce extracellular patterning information during axial skeleton development. An alternatively spliced transcript variant encoding a substantially different isoform has been described, but its biological validity has not been determined.
Alternative names: CMVFR
See Full Product Listings >